Key result
A clinical nomogram using BMI, serum potassium, and CT findings predicted idiopathic hyperaldosteronism with an AUC of 0.894 (95% CI 0.804-0.952) in the validation set.
Why the study?
Adrenal venous sampling is the gold standard for subtype classification in primary aldosteronism but has limited availability, motivating a predictive nomogram based on routine variables.
Does a clinical nomogram based on BMI, serum potassium, and CT findings accurately predict idiopathic hyperaldosteronism in Chinese patients with primary aldosteronism?
Observational (n=379)
Does a clinical nomogram based on BMI, serum potassium, and CT findings accurately predict idiopathic hyperaldosteronism in Chinese patients with primary aldosteronism?
A novel clinical nomogram using routine variables accurately predicts idiopathic hyperaldosteronism, potentially reducing the need for invasive adrenal venous sampling in patients with primary aldosteronism.
CONTEXT: Adrenal venous sampling (AVS) is recommended as the gold standard for subtype classification in primary aldosteronism (PA); however, this approach has limited availability. OBJECTIVE: We aimed to develop a novel clinical nomogram to predict PA subtype based on routine variables, thereby reducing the number of candidates for AVS. PATIENTS AND METHOD: Patients were randomly divided into a training set (n = 185) and a validation set (n = 79). Risk factors for idiopathic hyperaldosteronism (IHA) differentiating from aldosterone-producing adenoma (APA) were identified using logistic regression analysis. A nomogram was constructed to predict the probability of IHA. A receiver operating characteristic (ROC) curve and a calibration plot were applied to assess the predictive value. Then, 115 patients were prospectively enrolled, and a nomogram was used to predict the subtypes before AVS. RESULTS: Body mass index (BMI), serum potassium and computed tomography (CT) finding were adopted in the nomogram. The nomogram presented an area under the ROC (AUC) of 0.924 (95% CI: 0.875-0.957), sensitivity of 86.59% and specificity of 87.38% in the training set and an AUC of 0.894 (95% CI: 0.804-0.952), sensitivity of 82.86% and specificity of 84.09% in the validation set. Predicted probability and actual probability matched well in the nomogram (Hosmer-Lemeshow test: P > 0.05). Using the nomogram as a surrogate to predict IHA in the prospective set before AVS, the specificity reached 100% when we increased the threshold to a probability of 90%. CONCLUSION: We have developed a tool that is able to predict IHA in patients with PA and potentially avoid AVS.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2019) conducted an observational in Primary aldosteronism (n=379). Clinical nomogram (BMI, serum potassium, CT findings) vs. Adrenal venous sampling (AVS) was evaluated on Prediction of idiopathic hyperaldosteronism (IHA) (AUC 0.894, 95% CI 0.804-0.952). A clinical nomogram using BMI, serum potassium, and CT findings predicted idiopathic hyperaldosteronism with an AUC of 0.894 (95% CI 0.804-0.952) in the validation set.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: